CURRENT PHARMACEUTICAL DESIGN, vol.26, no.31, pp.3871-3883, 2020 (Journal Indexed in SCI)
Article / Review
Title of Journal :
CURRENT PHARMACEUTICAL DESIGN
Background: Schizophrenia belongs to mental illnesses affecting 1% of the worldwide population. Its therapy is still unmet; thus, researchers aimed to develop new pharmacological molecules which can improve its management.